All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report Open Access

Anaphylactic Reaction After Initial Exposure to Basiliximab


Balisiliximab is a widely used monoclonal antibody in renal transplant for immunosuppression induction. Its introduction has decreased the incidence in acute rejection during the first year after renal transplantation; however it does not show any long-term benefits. Case presentation: A 38 year old patient who suffers from a severe anaphylactic reaction after initial exposure to Basiliximab before kidney transplantation which led to his death.

Fragale Guillermo*, Lovisolo Patricia , Beitía Vanina and Martin Rodolfo

To read the full article Download Full Article | Visit Full Article